1. Home
  2. ACRV vs TDUP Comparison

ACRV vs TDUP Comparison

Compare ACRV & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • TDUP
  • Stock Information
  • Founded
  • ACRV 2018
  • TDUP 2009
  • Country
  • ACRV United States
  • TDUP United States
  • Employees
  • ACRV N/A
  • TDUP N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • TDUP Catalog/Specialty Distribution
  • Sector
  • ACRV Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • ACRV 170.3M
  • TDUP 172.9M
  • IPO Year
  • ACRV 2022
  • TDUP 2021
  • Fundamental
  • Price
  • ACRV $5.65
  • TDUP $2.26
  • Analyst Decision
  • ACRV Strong Buy
  • TDUP Buy
  • Analyst Count
  • ACRV 5
  • TDUP 5
  • Target Price
  • ACRV $22.40
  • TDUP $3.50
  • AVG Volume (30 Days)
  • ACRV 50.9K
  • TDUP 1.3M
  • Earning Date
  • ACRV 11-13-2024
  • TDUP 03-03-2025
  • Dividend Yield
  • ACRV N/A
  • TDUP N/A
  • EPS Growth
  • ACRV N/A
  • TDUP N/A
  • EPS
  • ACRV N/A
  • TDUP N/A
  • Revenue
  • ACRV N/A
  • TDUP $313,757,000.00
  • Revenue This Year
  • ACRV N/A
  • TDUP N/A
  • Revenue Next Year
  • ACRV N/A
  • TDUP N/A
  • P/E Ratio
  • ACRV N/A
  • TDUP N/A
  • Revenue Growth
  • ACRV N/A
  • TDUP 0.58
  • 52 Week Low
  • ACRV $3.19
  • TDUP $0.50
  • 52 Week High
  • ACRV $11.90
  • TDUP $2.45
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 41.71
  • TDUP 71.74
  • Support Level
  • ACRV $5.36
  • TDUP $1.21
  • Resistance Level
  • ACRV $6.00
  • TDUP $2.45
  • Average True Range (ATR)
  • ACRV 0.52
  • TDUP 0.21
  • MACD
  • ACRV -0.01
  • TDUP 0.09
  • Stochastic Oscillator
  • ACRV 17.74
  • TDUP 84.68

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: